To further test the effect of high DDX1 expression in cancer cells, we selected human neuroblastoma cell lines harboring MYCN amplifications, not including DDX1 and introduced a doxycycline-inducible DDX1 expression vector. The gene discussed is MYCN; the disease is cancer.